Asia-Pacific L-carnosine market is estimated to grow at a CAGR of around 5.3% during the forecast period. Increasing prevalence of chronic diseases is one of the key motivating factors for the growth of the market. For instance, the adult diabetic population in India was 69,188 cases per 100,000 people in 2018 with the prevalence rate reaching 9.3% as per World Health Organization (WHO). In 2018, over 1 million mortalities occurred due to diabetes in India. This, in turn, is expected to drive the demand for L-carnosine as a dietary supplement to improve glycaemic control in diabetes and support cardiovascular health.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/asia-pacific-l-carnosine-market
Asia-Pacific L-carnosine market is segmented on the basis of application and geography. Based on the application, the market is segmented into autism, diabetes support, skin support, CVD support, joint support, and others. Others segment include digestion support, Parkinson’s disease, and Alzheimer’s disease. In 2019, the skin support segment is projected to contribute a significant share to the global market.
Moreover, the report covers the country-level analysis of the Asia-Pacific L-carnosine market. The economies covered in the report studied include China, Japan, India, and Rest of Asia-Pacific. China is one of the largest economies across the globe and is known for its significant economic growth, healthcare system, infrastructure, and technological advancement. The geriatric population, healthcare reforms, and favorable regulations are estimated to back the growth of the market in the country. The market in China is backed by increasing diabetes and kidney-related cases along with the trend towards L-carnosine as a dietary supplement to support health and cardiovascular health.
Companies operating in the market include Hamari Chemicals, Ltd., Panvo Organics Pvt Ltd., Foodchem International Corp., Manus Akttevs Biopharma LLP, and Zeria Pharmaceutical Co., Ltd. Manus Akttevs Biopharma LLP offers products through three categories that include APIs, intermediates, and other products. Under the API category, L-carnosine offered by the company is supplied across the globe. The L-carnosine products are intended for the requirements of R&D quantities and commercials, based on the status of the product. The company also provides intermediates of L-Carnosine. Additionally, Foodchem International Corp. offers L-Carnosine in its food ingredient segment. The company is manufacturing and supplying L-Carnosine for more than 10 years. The company sells at least 5 kg of L-Carnosine directly.
Asia-Pacific L-Carnosine Market- Segmentation
By Application
- Autism
- Diabetes
- Skin Support
- Cardiovascular Support
- Joint Support
- Others
A full report of Asia-Pacific L-Carnosine Market is available at: https://www.omrglobal.com/industry-reports/asia-pacific-l-carnosine-market
Asia-Pacific L-Carnosine Market– Segment by Region
- China
- India
- Japan
- Rest of Asia-Pacific
Company Profiles
- Alpspure Lifesciences Pvt Ltd.
- Foodchem International Corp.
- Hamari Chemicals, Ltd.
- Manus Aktteva Biopharma LLP
- Panvo Organics Pvt Ltd.
- Puneet Laboratories Pvt. Ltd.
- Shaanxi Shineherb Biotech Co., Ltd.
- Wuhan W&Z Biotech Co., Ltd.
- Zeon Biotech
- Zeria Pharmaceutical Co., Ltd.
- Zhejiang Aiyi tech Co., Ltd.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +1 646-755-7667, +91 7803040404
